Target intelligence / Profile preview

Human immunoglobulin E specific for fish parvalbumin (IgE-anti-parvalbumin)

Target
IgE-anti-parvalbumin
Molecular classification
Immunoglobulin, Antibody
01

Overview

Human immunoglobulin E (IgE) antibodies specific for fish parvalbumin are the primary mediators of fish allergy, a common and often severe food hypersensitivity (Kuehn et al., 2014, PMID: 25617731). Parvalbumins are small, calcium-binding proteins found in high concentrations in the white muscle of fish and are recognized as the major allergen because they trigger IgE production in over 90% of fish-allergic individuals (Swoboda et al., 2002, PMID: 12063303). Upon exposure to fish, these specific IgE antibodies, which are typically bound to high-affinity receptors (FcεRI) on mast cells and basophils, cross-link with parvalbumin, leading to the immediate release of inflammatory mediators like histamine (Galli et al., 2012, PMID: 22559788). This process results in clinical symptoms ranging from mild urticaria to life-threatening anaphylaxis (Sharp and Lopata, 2014, PMID: 24611650). Therapeutic strategies targeting these antibodies include the use of anti-IgE monoclonal antibodies like omalizumab, which sequester free IgE and prevent its binding to effector cells (Swinyard et al., 2022, PMID: 35123114). Additionally, allergen-specific immunotherapy (AIT) is under investigation to desensitize patients by inducing IgG4 antibodies that compete with IgE for parvalbumin binding (Akdis and Akdis, 2014, PMID: 25441638). Diagnostic monitoring of these antibodies via serum specific IgE levels is crucial for managing patient risk and evaluating the efficacy of emerging treatments (Kuehn et al., 2014, PMID: 25617731).

Other names
Fish-specific IgEAnti-parvalbumin IgEParvalbumin-specific IgEGad m 1-specific IgECyp c 1-specific IgE
02

Mechanism of action

Neutralization of circulating IgE and prevention of binding to the high-affinity IgE receptor (FcεRI) on mast cells and basophils.

03

Biological functions

Immune responseType I hypersensitivityMast cell degranulation
04

Disease associations

Fish allergyAnaphylaxisFood allergy
05

Safety considerations

Risk of anaphylaxis during allergen exposure or immunotherapyPotential for systemic allergic reactionsTheoretical risk of impaired defense against parasitic infections
06

Interacting drugs

Omalizumab

2 more in the full profile.

07

Biomarkers

Serum specific IgE (sIgE) levelsBasophil activation test (BAT)Skin prick test (SPT)

Beyond the preview

Go deeper on Human immunoglobulin E specific for fish parvalbumin (IgE-anti-parvalbumin).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human immunoglobulin E specific for fish parvalbumin (IgE-anti-parvalbumin).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call